Cecilia Smith Simonsen

  • PhD student; MD

Cecilia Smith Simonsen has a medical degree from The University of Glasgow, Scotland (2007). She did her foundation years in Greater Glasgow and started her neurology training at the Hospital of Telemark in Skien in 2010 and later at Drammen Hospital (VVHF). As of 2015 she has been working 50% as a clinical registrar at the department of neurology in Drammen and 50% as a researcher in the MS group at Oslo University Hospital.

Research project:  Cecilia Smith Simonsen is doing her PhD project on multiple sclerosis and NEDA. The project title is "Predictors for disease susceptibility and disease progression in Multiple sclerosis." The aims are to determine the proportion of all MS patients in Oslo, Buskerud and Telemark achieving NEDA, the natural course of the disease and predictors for disease susceptibility, progression and NEDA.

Main supervisor: Elisabeth Gulowsen Celius (MD, PhD)
Co-supervisors: Stine Marit Moen (MD, PhD) and Kari Anne Bjørnarå (MD, PhD, senior consultant at department of neurology, Drammen Hospital)

Methodology and interests:

  • Epidemiology
  • Clinical research and clinical trials in MS
  • MS and bone health
 

Publications 2024

Simonsen CS, Flemmen HØ, Broch L, Myklebust H, Berg-Hansen P, Brunborg C, Celius EG (2024)
The influence of menopause on multiple sclerosis
Eur J Neurol, 32 (1), e16566
DOI 10.1111/ene.16566, PubMed 39601490

Publications 2023

Broch L, Flemmen HØ, Simonsen CS, Berg-Hansen P, Ormstad H, Brunborg C, Celius EG (2023)
"No association between disease modifying treatment and fatigue in multiple sclerosis"
Mult Scler Relat Disord, 79, 104993
DOI 10.1016/j.msard.2023.104993, PubMed 37708819

Publications 2022

Broch L, Flemmen HØ, Simonsen CS, Berg-Hansen P, Ormstad H, Brunborg C, Celius EG (2022)
Fatigue in multiple sclerosis is associated with socioeconomic factors
Mult Scler Relat Disord, 64, 103955
DOI 10.1016/j.msard.2022.103955, PubMed 35753177

Flemmen HØ, Simonsen CS, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Kersten H, Celius EG (2022)
The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort
Mult Scler Relat Disord, 61, 103759
DOI 10.1016/j.msard.2022.103759, PubMed 35358792

Simonsen CS, Flemmen HØ, Broch L, Brekke K, Brunborg C, Berg-Hansen P, Celius EG (2022)
Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
Front Neurol, 13, 1034056
DOI 10.3389/fneur.2022.1034056, PubMed 36452173

Publications 2021

Broch L, Simonsen CS, Flemmen HØ, Berg-Hansen P, Skardhamar Å, Ormstad H, Celius EG (2021)
High prevalence of fatigue in contemporary patients with multiple sclerosis
Mult Scler J Exp Transl Clin, 7 (1), 2055217321999826
DOI 10.1177/2055217321999826, PubMed 33796331

Eid K, Torkildsen ØF, Aarseth J, Flemmen HØ, Holmøy T, Lorentzen ÅR, Myhr KM, Riise T, Simonsen C, Torkildsen CF, Wergeland S, Willumsen JS, Øksendal N, Gilhus NE, Bjørk MH (2021)
Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
Neurology, 96 (23), e2789-e2800
DOI 10.1212/WNL.0000000000012062, PubMed 33883236

Flemmen HØ, Simonsen CS, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Kersten H, Celius EG (2021)
Maternal education has significant influence on progression in multiple sclerosis
Mult Scler Relat Disord, 53, 103052
DOI 10.1016/j.msard.2021.103052, PubMed 34111658

Simonsen CS, Flemmen HØ, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2021)
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
Front Neurol, 12, 693017
DOI 10.3389/fneur.2021.693017, PubMed 34220694

Simonsen CS, Flemmen HØ, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2021)
No significant differences in absenteeism or academic achievements in a Norwegian multiple sclerosis case control study
Mult Scler Relat Disord, 54, 103141
DOI 10.1016/j.msard.2021.103141, PubMed 34273610

Publications 2020

Flemmen HØ, Simonsen CS, Berg-Hansen P, Moen SM, Kersten H, Heldal K, Celius EG (2020)
Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
Mult Scler Relat Disord, 45, 102352
DOI 10.1016/j.msard.2020.102352, PubMed 32707528

Ormstad H, Simonsen CS, Broch L, Maes DM, Anderson G, Celius EG (2020)
Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways
Mult Scler Relat Disord, 46, 102533
DOI 10.1016/j.msard.2020.102533, PubMed 33010585

Simonsen CS, Flemmen HØ, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2020)
The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression
J Neurol, 268 (4), 1330-1341
DOI 10.1007/s00415-020-10279-7, PubMed 33090270

Simonsen CS, Flemmen HØ, Lauritzen T, Berg-Hansen P, Moen SM, Celius EG (2020)
The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis
Mult Scler J Exp Transl Clin, 6 (1), 2055217319901291
DOI 10.1177/2055217319901291, PubMed 32030196

Publications 2016

Simonsen CS, Celius EG, Brunborg C, Tallaksen C, Eriksen EF, Holmøy T, Moen SM (2016)
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
BMC Neurol, 16 (1), 252
DOI 10.1186/s12883-016-0771-4, PubMed 27919248

Simonsen CS, Edland A, Berg-Hansen P, Celius EG (2016)
High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud
Acta Neurol Scand, 135 (4), 412-418
DOI 10.1111/ane.12615, PubMed 27241360

Simonsen CS, Hansen G, Piehl F, Edland A (2016)
Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis
Mult Scler J Exp Transl Clin, 2, 2055217316658304
DOI 10.1177/2055217316658304, PubMed 28607734

Scroll to top